IL6 and COVID-19: Moreover, the systemic inflammatory response triggered by COVID-19, characterized by elevated levels of pro-inflammatory cytokines (e.g., IL-6, TNF-a), can exacerbate liver injury through immune-mediated mechanisms and microvascular thrombosis (Sanyaolu et al., 2023).